English
Zoom-Zoom+Black contrastBlue contrastWhite contrast

How to use the speech recognition tool?

NCT01367444

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration

Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration.

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2011-05-15
  • Closing Date: 2019-05-15

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: